Rebecca Luse joined New Leaf as an Associate in 2015. Prior to joining New Leaf, Rebecca was a Research Senior Associate for Biotechnology at Jefferies. She previously was a Research Associate for Specialty Pharmaceuticals at Piper Jaffray, an Analyst at Bay City Capital and a Healthcare Investment Banking Analyst at Banc of America Securities. Rebecca received her B.S. in Biochemistry and B.S. in Mathematics, with minors in French and Economics, at Indiana University.